BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35326746)

  • 1. Genomics of Plasma Cell Leukemia.
    Rojas EA; Gutiérrez NC
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population.
    Dubey H; Goel H; Verma S; Gupta S; Tanwar K; Rahul E; Kapoor G; Vasantharaman J; Ranjan A; Tanwar P; Chopra A
    Am J Blood Res; 2022; 12(6):190-195. PubMed ID: 36742277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells.
    Papadhimitriou SI; Terpos E; Liapis K; Pavlidis D; Marinakis T; Kastritis E; Dimopoulos MA; Tsitsilonis OE; Kostopoulos IV
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
    Guan J; Ma J; Chen B
    Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis].
    Jurczyszyn A; Zawirska D; Skotnicki AB
    Przegl Lek; 2011; 68(6):320-5. PubMed ID: 22039670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature.
    Bommannan K; Sachdeva MU; Malhotra P; Kumar N; Sharma P; Naseem S; Ahluwalia J; Das R; Varma N; Prakash G; Khadwal A; Srinivasan R; Varma S
    Blood Res; 2016 Mar; 51(1):23-30. PubMed ID: 27104188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature.
    Gangadhar P; Ahmed Z; Pai MR; Sandhya I
    Indian J Pathol Microbiol; 2016; 59(4):541-544. PubMed ID: 27721294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis.
    Jimenez-Zepeda VH; Dominguez-Martinez VJ
    Int J Hematol; 2009 Apr; 89(3):259-268. PubMed ID: 19326058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma.
    Lee Y; Yun J; Jeong D; Ryu S; Kwon SR; Yun H; Kim SM; Park JH; Lee DS
    Leuk Lymphoma; 2022 Feb; 63(2):385-394. PubMed ID: 34592901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cell leukemia: a rare condition.
    Jiménez-Zepeda VH; Domínguez VJ
    Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Center Experience of Patients with Plasma Cell Leukemia in the Era of New Therapeutics.
    Dampmann M; Flossdorf S; Keyl J; Reinhardt HC; Hanoun C
    Acta Haematol; 2024 May; ():1-8. PubMed ID: 38763126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study.
    Wang H; Zhou H; Zhang Z; Geng C; Chen W
    Turk J Haematol; 2020 May; 37(2):91-97. PubMed ID: 31769277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired del(9)(p22.3) in a primary plasma cell leukemia.
    Achkar WA; Wafa A; Aljapawe A; Othman MA; Alhourani E; Liehr T
    Mol Cytogenet; 2013 Aug; 6(1):33. PubMed ID: 23985162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cell leukemia: update on biology and therapy.
    Mina R; D'Agostino M; Cerrato C; Gay F; Palumbo A
    Leuk Lymphoma; 2017 Jul; 58(7):1538-1547. PubMed ID: 27819179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Current State of Knowledge About Evolution of Multiple Myeloma to Plasma Cell Leukemia.
    Jurczyszyn A; Olszewska-Szopa M; Vesole DH
    Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):188-193. PubMed ID: 36593169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic aberrations and survival in plasma cell leukemia.
    Tiedemann RE; Gonzalez-Paz N; Kyle RA; Santana-Davila R; Price-Troska T; Van Wier SA; Chng WJ; Ketterling RP; Gertz MA; Henderson K; Greipp PR; Dispenzieri A; Lacy MQ; Rajkumar SV; Bergsagel PL; Stewart AK; Fonseca R
    Leukemia; 2008 May; 22(5):1044-52. PubMed ID: 18216867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.
    Todoerti K; Agnelli L; Fabris S; Lionetti M; Tuana G; Mosca L; Lombardi L; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Omede' P; Tassone P; Boccadoro M; Palumbo A; Neri A; Musto P
    Clin Cancer Res; 2013 Jun; 19(12):3247-58. PubMed ID: 23599371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?
    Suska A; Vesole DH; Castillo JJ; Kumar SK; Parameswaran H; Mateos MV; Facon T; Gozzetti A; Mikala G; Szostek M; Mikhael J; Hajek R; Terpos E; Jurczyszyn A
    Clin Hematol Int; 2020 Dec; 2(4):133-142. PubMed ID: 34595454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile.
    Hofste Op Bruinink D; Kuiper R; van Duin M; Cupedo T; van der Velden VHJ; Hoogenboezem R; van der Holt B; Beverloo HB; Valent ET; Vermeulen M; Gay F; Broijl A; Avet-Loiseau H; Munshi NC; Musto P; Moreau P; Zweegman S; van de Donk NWCJ; Sonneveld P
    J Clin Oncol; 2022 Sep; 40(27):3132-3150. PubMed ID: 35357885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns.
    Schinke C; Boyle EM; Ashby C; Wang Y; Lyzogubov V; Wardell C; Qu P; Hoering A; Deshpande S; Ryan K; Thanendrarajan S; Mohan M; Yarlagadda N; Khan M; Choudhury SR; Zangari M; van Rhee F; Davies F; Barlogie B; Morgan G; Walker BA
    Blood Cancer J; 2020 Jun; 10(6):70. PubMed ID: 32555163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.